Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04551495
Title Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) (ROSALINE)
Acronym ROSALINE
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Jules Bordet Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
UZ Brussel Brussels 1090 Belgium Details
UCL Saint-Luc Brussels 1200 Belgium Details
Institut Jules Bordet Bruxelles 1070 Belgium Details
Grand Hôpital de Charleroi Charleroi 6000 Belgium Details
UZ Gent Gent 9000 Belgium Details
UZ Leuven Leuven 3000 Belgium Details
CHU Namur - Sainte Elisabeth Namur 5000 Belgium Details
Institut Bergonié Bordeaux 33076 France Details
Institut Curie Paris 75248 France Details
Institut Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field